carmustine has been researched along with Neurilemoma in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Excerpt | Relevance | Reference |
---|---|---|
"Forty-three patients with brain tumors were entered into the study." | 1.29 | Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy. ( Kowada, M; Mineura, K; Watanabe, K; Yanagisawa, T; Yasui, N, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mineura, K | 1 |
Yanagisawa, T | 1 |
Watanabe, K | 1 |
Kowada, M | 1 |
Yasui, N | 1 |
Weiss, Ede C | 1 |
Cravioto, H | 1 |
Weiss, JF | 1 |
Ransohoff, J | 1 |
2 other studies available for carmustine and Neurilemoma
Article | Year |
---|---|
Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy.
Topics: Antineoplastic Agents, Alkylating; Biomarkers; Brain Neoplasms; Carmustine; DNA Repair; Glioma; Huma | 1996 |
Brief communication: Pathologic effects in rats surviving prenatal and neonatal administration of 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Animals; Animals, Newborn; Carcinogens; Carmustine; Female; Liver; Maternal-Fetal Exchange; Neoplasm | 1973 |